This email notifications is intended as a heads up to OHSU communicators. It is not shared with external subscribers.
|
OHSU researchers ‘instrumental’ in studying newly FDA-approved treatment for a form of prostate cancerThe OHSU Knight Cancer Institute is among top sites for enrolling subjects in international clinical trial.
|
|
This email was sent to you by Oregon Health & Science University 3181 S.W. Sam Jackson Park Rd. | Portland, Oregon 97239-3098 |